Patients with ankylosing spondylitis (AS) may require biological therapy, particularly tumour necrosis factor (TNF) inhibitors, which are effective but increase the risk of tuberculosis (TB).
The Global Edge AI Chipsets Market was valued at USD 4.23 billion in 2024 and is projected to reach USD 48.4 billion by 2034, ...
Epanko Expansion Supports EcoGraf HFfree®Downstream Facilities Staged Expansion to 390,000 tpa to become Africa's Largest Planned Graphite Producer EcoGraf Limited is pleased to announce the Epanko ...